{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:02:13Z","timestamp":1771326133483,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T00:00:00Z","timestamp":1385337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.clinthera.2013.11.005","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T22:45:21Z","timestamp":1387320321000},"page":"141-150","source":"Crossref","is-referenced-by-count":32,"title":["Zopiclone\u2019s Residual Effects on Actual Driving Performance in a Standardized Test: A Pooled Analysis of Age and Sex Effects in 4 Placebo-Controlled Studies"],"prefix":"10.1016","volume":"36","author":[{"given":"Tim R.M.","family":"Leufkens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vermeeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.11.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta8240","article-title":"Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation","volume":"8","author":"D\u00fcndar","year":"2004","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.clinthera.2013.11.005_bib2","first-page":"213","article-title":"Use of prescription and nonprescription hypnotics in a Canadian elderly population","volume":"8","author":"Busto","year":"2001","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2013.11.005_bib3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1360-0443.2003.00491.x","article-title":"Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data","volume":"98","author":"Hajak","year":"2003","journal-title":"Addict Abingdon Engl"},{"key":"10.1016\/j.clinthera.2013.11.005_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/070674370605100504","article-title":"Sedative hypnotic use in Alberta","volume":"51","author":"Kassam","year":"2006","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clinthera.2013.11.005_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3399\/bjgp08X299290","article-title":"Magic bullets for insomnia? Patients\u2019 use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care","volume":"58","author":"Siriwardena","year":"2008","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.clinthera.2013.11.005_bib6","unstructured":"CVZ. Aantal voorschriften 2003-2007 voor ATC-subgroep N05C\u202f: Hypnotica en sedativa (Number of prescriptions of ATC-subgroup N05C: Hypnotics and sedatives). http:\/\/www.gipdatabank.nl\/. Accessed July 18, 2013."},{"key":"10.1016\/j.clinthera.2013.11.005_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/hup.445","article-title":"Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement","volume":"18","author":"Montplaisir","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.clinthera.2013.11.005_bib8","first-page":"964","article-title":"GPs\u2019 attitudes to benzodiazepine and \u201cZ-drug\u201d prescribing: a barrier to implementation of evidence and guidance on hypnotics","volume":"56","author":"Siriwardena","year":"2006","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.clinthera.2013.11.005_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMp1307972","article-title":"Zolpidem and driving impairment\u2014identifying persons at risk","volume":"369","author":"Farkas","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.11.005_bib10","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/(SICI)1099-1077(1998110)13:2+<S98::AID-HUP54>3.0.CO;2-1","article-title":"Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance","volume":"13","author":"Vermeeren","year":"1998","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.clinthera.2013.11.005_bib11","first-page":"224","article-title":"Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol","volume":"25","author":"Vermeeren","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.clinthera.2013.11.005_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2869.2009.00746.x","article-title":"Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem","volume":"18","author":"Leufkens","year":"2009","journal-title":"J Sleep Res"},{"key":"10.1016\/j.clinthera.2013.11.005_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/JCP.0b013e3181b57b43","article-title":"Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo","volume":"29","author":"Leufkens","year":"2009","journal-title":"J Clin Psychopharmacol"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2013.11.005_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000137914","article-title":"Pharmacokinetics and metabolism of zopiclone","volume":"27","author":"Gaillot","year":"1983","journal-title":"Pharmacology"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.11.005_bib15","first-page":"7","article-title":"Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency","volume":"10","author":"Gaillot","year":"1987","journal-title":"Sleep"},{"key":"10.1016\/j.clinthera.2013.11.005_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.clpt.2004.07.009","article-title":"Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate","volume":"76","author":"Greenblatt","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2013.11.005_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003088-200544010-00002","article-title":"The influence of age and sex on the clearance of cytochrome P450 3A substrates","volume":"44","author":"Cotreau","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.11.005_bib18","doi-asserted-by":"crossref","first-page":"121s","DOI":"10.1111\/j.1365-2125.1984.tb02590.x","article-title":"Driving performance under the influence of drugs: rationale for, and application of, a new test","volume":"18","author":"O\u2019Hanlon","year":"1984","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2013.11.005_bib19","doi-asserted-by":"crossref","first-page":"137s","DOI":"10.1016\/0924-9338(96)80095-2","article-title":"Zopiclone\u2019s residual effects on psychomotor and information processing skills involved in complex tasks such as car driving: a critical review","volume":"10","author":"O\u2019Hanlon","year":"1995","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.clinthera.2013.11.005_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1398-9995.1995.tb01140.x","article-title":"Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94","volume":"50","author":"O\u2019Hanlon","year":"1995","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2013.11.005_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4088\/JCP.v64n0106","article-title":"Antidepressants and driver impairment: empirical evidence from a standard on-the-road test","volume":"64","author":"Ramaekers","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2013.11.005_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00023210-200418050-00003","article-title":"Residual effects of hypnotics: epidemiology and clinical implications","volume":"18","author":"Vermeeren","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinthera.2013.11.005_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1573400054065613","article-title":"Is it safe to drive a car when treated with anxiolytics? Evidence from on-the-road driving studies during normal traffic","volume":"1","author":"Verster","year":"2005","journal-title":"Curr Psychiatry Rev"},{"key":"10.1016\/j.clinthera.2013.11.005_bib24","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00213-006-0669-8","article-title":"Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg","volume":"191","author":"Leufkens","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinthera.2013.11.005_bib25","first-page":"183","article-title":"The relationship between drivers\u2019 blood alcohol concentration (BAC) and actual driving performance during high speed travel","volume":"T86","author":"Louwerens","year":"1987","journal-title":"Alcohol, Drugs Traffic Saf"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.11.005_bib26","first-page":"1","article-title":"The role of drinking driver in traffic accidents: the Grand Rapids Study","volume":"11","author":"Borkenstein","year":"1974","journal-title":"Blutalkohol"},{"key":"10.1016\/j.clinthera.2013.11.005_bib27","series-title":"Drugs, Driving and Traffic Safety","first-page":"43","article-title":"Drugs, driving, and models to measure driving impairment","author":"Owens","year":"2009"},{"key":"10.1016\/j.clinthera.2013.11.005_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1037\/1082-989X.1.2.170","article-title":"Meta-analysis of experiments with matched groups or repeated measures designs","volume":"1","author":"Dunlap","year":"1996","journal-title":"Psychol Methods"},{"key":"10.1016\/j.clinthera.2013.11.005_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0001-4575(02)00134-3","article-title":"The alcohol-related accident risk in Germany: procedure, methods and results","volume":"36","author":"Kr\u00fcger","year":"2004","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.clinthera.2013.11.005_bib30","unstructured":"Wolschrijn H, De Gier JJ, De Smet PAGM. Drugs and Driving: A New Categorization System for Drugs Affecting Psychomotor Performance. Maastricht, the Netherlands: Institute for Drugs, Safety and Behaviour, University of Limburg; 1991:24."},{"key":"10.1016\/j.clinthera.2013.11.005_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s002130050961","article-title":"Residual effect of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades","volume":"143","author":"Bocca","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinthera.2013.11.005_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/02698811030173015","article-title":"Do zopiclone, zolpidem and flunitrazepam have residual effects on simulated task of collision anticipation?","volume":"17","author":"Berthelon","year":"2003","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2013.11.005_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.erap.2006.06.001","article-title":"Residual effects of zolpidem, zopiclone and flunitrazepam on the processing of visual information in driving context","volume":"58","author":"Berthelon","year":"2008","journal-title":"Rev Eur Psychol Appliqu\u00e9e"},{"key":"10.1016\/j.clinthera.2013.11.005_bib34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/15389580802161943","article-title":"The impact of benzodiazepines on safe driving","volume":"9","author":"Dubois","year":"2008","journal-title":"Traffic Inj Prev"},{"key":"10.1016\/j.clinthera.2013.11.005_bib35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/15389588.2011.652751","article-title":"Gender differences in highway driving performance after administration of sleep medication: a review of the literature","volume":"13","author":"Verster","year":"2012","journal-title":"Traffic Inj Prev"},{"key":"10.1016\/j.clinthera.2013.11.005_bib36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-3565(24)39253-5","article-title":"Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences","volume":"293","author":"Greenblatt","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2013.11.005_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(08)00001-9","article-title":"Gender differences in pharmacological response","volume":"83","author":"Anderson","year":"2008","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.clinthera.2013.11.005_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/026988110201600104","article-title":"Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females","volume":"16","author":"Vermeeren","year":"2002","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2013.11.005_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003088-200342020-00001","article-title":"The influence of sex on pharmacokinetics","volume":"42","author":"Schwartz","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2013.11.005_bib40","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1177\/0091270008323754","article-title":"Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs","volume":"48","author":"Greenblatt","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2013.11.005_bib41","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1111\/j.1365-2125.2004.02308.x","article-title":"Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program. 1978","volume":"58","author":"Greenblatt","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2013.11.005_bib42","article-title":"Effects of low and moderate doses of alcohol on actual driving in young novice drivers compared to experienced drivers","author":"Vuurman","year":"2009","journal-title":"Intern Rep"},{"key":"10.1016\/j.clinthera.2013.11.005_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1381612023396681","article-title":"Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal","volume":"8","author":"Bateson","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.clinthera.2013.11.005_bib44","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/(SICI)1099-1077(1998110)13:2+<S115::AID-HUP56>3.0.CO;2-O","article-title":"Benzodiazepine-related traffic accidents in young and elderly drivers","volume":"13","author":"Neutel","year":"1998","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.clinthera.2013.11.005_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","article-title":"The use of analogue scales in rating subjective feelings","volume":"47","author":"Bond","year":"1974","journal-title":"Br J Med Psychol"},{"key":"10.1016\/j.clinthera.2013.11.005_bib46","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1517\/17425255.2012.741588","article-title":"Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications","volume":"8","author":"Greenblatt","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813010990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813010990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T06:35:38Z","timestamp":1746081338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291813010990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0149291813010990"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.11.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}